Newsletters

Recent Newsletters

• 

  The Science of Aging: Spring/Summer 2025

  Read More about The Science of Aging: Spring/Summer 2025
  

  The Science of Aging: Spring/Summer 2025

  In this issue:

  • FDA Approves First Blood Test Used in Diagnosing Alzheimer's Disease
  • The Cost of Dementia
  • Awards & Accolades
  • IOA-Funded Research: Newly funded Alzheimer's Disease Therapeutics Accelerator Project

  • Farraday Johnson: From STAR Intern to Penn Memory Center Coordinator

  • Research Highlight: Clinical Criteria for LATE

  Download here.

  Close modal dialog
• 

  The Science of Aging: Fall 2024

  Read More about The Science of Aging: Fall 2024
  

  The Science of Aging: Fall 2024

  In this issue:

  • Developing a Novel Gene Therapy for Alzheimer's Disease
  • CNDR-51997 as a Potential Disease-Modifying Alzheimer's Treatment
  • What Causes Cognitive Decline in Lewy Body Diseases?
  • Penn Medicine Expands Access to Geriatric Care in Eastern PA
  • Decision-making for Aging in Place
  • Additional stories

  Download here.

  Close modal dialog
• 

  The Science of Aging: Spring 2024

  Read More about The Science of Aging: Spring 2024
  

  The Science of Aging: Spring 2024

  In this issue:

  • New treatment reverses signs of Alzheimer's Disease, Penn Medicine research suggests
  • IOA Selects first three Alzheimer's Disease Therapeutics Accelerator Projects
  • Penn study evaluates palliative care strategy to better support seriously ill patients in the hospital
  • and more!

  Download Here. 

  Close modal dialog
• 

  The Science of Aging: Fall 2023

  Read More about The Science of Aging: Fall 2023
  

  The Science of Aging: Fall 2023

  In this issue:

  • Detailed 3D Mapping of AD Pathology Using Ex Vivo Imaging of the MTL

  • Penn Researcher leads $40.5 Million Multisite Study on Asian Cohort for AD

  • The FDA Fully Approves Lecanemab

  • IOA Division Highlights

  Download here.

  Close modal dialog